HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Harpaz, D. Search for Related Content PubMed PubMed Citation Articles by Harpaz, D.

Complete atrioventricular block complicating acute myocardial infarction in the thrombolytic era

David Harpaz, MD^*, Solomon Behar, MD, Shmuel Gottlieb, MD, Valentina Boyko, MSc, Yehezkiel Kishon, MD^*, Michael Eldar, MD, FACC for the SPRINT Study Group the Israeli Thrombolytic Survey Group

^* Heart Institute, E. Wolfson Medical Center, Holon, Israel
Neufeld Cardiac Research Institute, Chaim Sheba Medical Center, Tel-Hashomer, Israel
Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) research group centers and investigators, Israel
Israeli Thrombolytic Survey Group centers and investigators are listed in the Appendices, Israel

View larger version (13K): [in a new window]   Figure 1 One-year survival curves for patients with and without CAVB complicating AMI in the thrombolytic surveys (p by the log-rank test = 0.0001).

View larger version (16K): [in a new window]   Figure 2 One-year survival curves for patients with CAVB complicating AMI in the prethrombolytic and thrombolytic eras. TTx (+) = thrombolytic therapy; TTx (–) = no thrombolytic therapy. When comparing the thrombolysed groups in 1992 and 1996 with the 1981 to 1983 cohort, p = 0.006.